Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high‐resolution PET study
暂无分享,去创建一个
Claude Comtat | Eric Artiges | Edouard Duchesnay | Laurent Karila | Claire Leroy | Frédéric Dollé | E. Duchesnay | C. Comtat | J. Martinot | E. Artiges | M. Ribeiro | C. Trichard | A. Benyamina | F. Dollé | C. Leroy | L. Karila | Amine Benyamina | Christian Trichard | Michel Reynaud | Jean‐Luc Martinot | Michaël Lukasiewicz | Maria‐Joao Ribeiro | M. Reynaud | M. Lukasiewicz
[1] Matthijs G. Bossong,et al. Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum , 2008, NeuroImage.
[2] Zhuang-Wei Xiao,et al. Changes of dopamine transporter function in striatum during acute morphine addiction and its abstinence in rhesus monkey. , 2006, Chinese medical journal.
[3] Iwao Kanno,et al. Enhanced dopamine release by nicotine in cigarette smokers: a double-blind, randomized, placebo-controlled pilot study. , 2008, The international journal of neuropsychopharmacology.
[4] A. Lammertsma,et al. Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.
[5] Pirkko Räsänen,et al. Dopamine receptors and transporters in the brain reward circuits of type 1 and 2 alcoholics measured with human whole hemisphere autoradiography☆ , 2003, NeuroImage.
[6] Karl J. Friston,et al. Statistical parametric maps in functional imaging: A general linear approach , 1994 .
[7] Paul J. Laurienti,et al. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets , 2003, NeuroImage.
[8] Vincent J. Cunningham,et al. Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model , 1997, NeuroImage.
[9] T. Kirkham,et al. Endocannabinoids in the regulation of appetite and body weight , 2005, Behavioural pharmacology.
[10] Christer Halldin,et al. Measurement of Striatal and Extrastriatal Dopamine Transporter Binding with High-Resolution PET and [11C]PE2I: Quantitative Modeling and Test—Retest Reproducibility , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[11] Jeffrey H. Meyer,et al. Smoking-induced ventral striatum dopamine release. , 2004, The American journal of psychiatry.
[12] Rita Z. Goldstein,et al. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. , 2002, The American journal of psychiatry.
[13] D. Guilloteau,et al. Visualization of the Dopamine Transporter in the Human Brain Postmortem with the New Selective Ligand [125I]PE2I , 1999, NeuroImage.
[14] R. Metzger,et al. Rapid and reversible effects of methamphetamine on dopamine transporters. , 1997, The Journal of pharmacology and experimental therapeutics.
[15] Alain Dagher,et al. The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [11C]raclopride , 2004, Synapse.
[16] J. McEvoy,et al. Striatal dopamine D2/D3 receptor availability in male smokers , 2006, Psychiatry Research: Neuroimaging.
[17] F. Yasuno,et al. Role of Ventral Striatal Dopamine D1 Receptor in Cigarette Craving , 2007, Biological Psychiatry.
[18] Gwenn S. Smith,et al. Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography , 2008, Psychopharmacology.
[19] C. Hart,et al. Neuropsychological deficits in long-term frequent cannabis users , 2006, Neurology.
[20] N. Volkow,et al. Imaging dopamine's role in drug abuse and addiction , 2009, Neuropharmacology.
[21] Gerome Breen,et al. Can recreational doses of THC produce significant dopamine release in the human striatum? , 2009, NeuroImage.
[22] J. Swanson,et al. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications , 2004, Molecular Psychiatry.
[23] J. Heikkilä,et al. Dopamine transporters increase in human brain after alcohol withdrawal , 1999, Molecular Psychiatry.
[24] G. Di Chiara,et al. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[25] Hans-Georg Buchholz,et al. Association of low striatal dopamine d2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse. , 2008, The American journal of psychiatry.
[26] Ralph Myers,et al. Assessment of Spatial Normalization of PET Ligand Images Using Ligand-Specific Templates , 1999, NeuroImage.
[27] Caryn Lerman,et al. Dopamine Transporter Binding in Smokers and Nonsmokers , 2007, Clinical nuclear medicine.
[28] Nora D. Volkow,et al. The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies , 2004, Neuropharmacology.
[29] Po See Chen,et al. Decreased dopamine transporter availability in male smokers — A dual isotope SPECT study , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[30] Joseph A Maldjian,et al. Precentral gyrus discrepancy in electronic versions of the Talairach atlas , 2004, NeuroImage.
[31] Jennifer M. Mitchell,et al. Behavioural and biochemical evidence for interactions between Δ9‐tetrahydrocannabinol and nicotine , 2002, British journal of pharmacology.
[32] Edythe D London,et al. Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. , 2006, Archives of general psychiatry.
[33] Claude Comtat,et al. Assessment of 11C-PE2I Binding to the Neuronal Dopamine Transporter in Humans with the High-Spatial-Resolution PET Scanner HRRT , 2007, Journal of Nuclear Medicine.
[34] R N Gunn,et al. Reduced dopamine D1 receptor binding in the ventral striatum of cigarette smokers , 2001, Synapse.
[35] E. Perry,et al. Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use , 1998, Neuroscience.
[36] Jean-Luc Anton,et al. Region of interest analysis using an SPM toolbox , 2010 .
[37] Alice Egerton,et al. The effect of nicotine on striatal dopamine release in man: A [11C]raclopride PET study , 2007, Synapse.
[38] N. Rathod. Society for the Study of Addiction , 1977 .
[39] Jean-Francois Mangin,et al. A structural browser for human brain mapping , 2000, NeuroImage.
[40] L. Kozlowski,et al. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.
[41] R. Murray,et al. Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study , 2011, Journal of psychopharmacology.
[42] M Fujita,et al. Sex differences in [123I]β‐CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers , 2001, Synapse.
[43] Robert A Koeppe,et al. Smoking Modulation of μ-Opioid and Dopamine D2 Receptor-Mediated Neurotransmission in Humans , 2007, Neuropsychopharmacology.
[44] A. Galli,et al. Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine. , 2003, European journal of pharmacology.
[45] J. Seibyl,et al. Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[46] G. Di Chiara,et al. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. , 1997, Science.
[47] J. Monterosso,et al. Ventral Striatal Dopamine Release in Response to Smoking a Regular vs a Denicotinized Cigarette , 2009, Neuropsychopharmacology.
[48] Ronald Boellaard,et al. Performance evaluation of the ECAT HRRT: an LSO-LYSO double layer high resolution, high sensitivity scanner , 2007, Physics in medicine and biology.
[49] M. Picciotto. Nicotine as a modulator of behavior: beyond the inverted U. , 2003, Trends in pharmacological sciences.
[50] R. Wightman,et al. Cannabinoids Enhance Subsecond Dopamine Release in the Nucleus Accumbens of Awake Rats , 2004, The Journal of Neuroscience.
[51] E. Gardner. Endocannabinoid signaling system and brain reward: Emphasis on dopamine , 2005, Pharmacology Biochemistry and Behavior.